Last reviewed · How we verify

NCT06645756: CAPE

Comparative Analysis of Postprandial Effects in Healthy and Obese Individuals

Completed NA Last updated 6 August 2025
What this trial tests

NA trial testing Test meal in Obesity in 38 participants. Completed in 6 November 2024.

Timeline
13 December 2023
Primary endpoint
6 November 2024
6 November 2024

Quick facts

Lead sponsorUniversity of Hohenheim
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment38
Start date13 December 2023
Primary completion6 November 2024
Estimated completion6 November 2024
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Hohenheim

Who can join

25 and older, any sex, with Obesity or Normal Weigth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After eating, blood composition changes, including increased triglycerides and glucose, which can trigger postprandial inflammation. Particularly with high-fat foods, pro-inflammatory lipopolysaccharide (LPS) increases. This activates leukocytes to release pro-inflammatory cytokines. In industrialized countries where "snacking" is common, many people spend the day in a postprandial state. Obese individuals tend to have chronic inflammation and show increased susceptibility to infections such as SARS-CoV-2. The main objective of the study is to investigate the response of leukocytes and the serum metabolome after food intake in individuals with obesity compared to healthy individuals, focusing on LPS as a key stimulus of innate immunity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Test meal

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other University of Hohenheim trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06645756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing